Logo image of TMO

THERMO FISHER SCIENTIFIC INC (TMO) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:TMO - US8835561023 - Common Stock

618.72 USD
-5.93 (-0.95%)
Last: 1/16/2026, 8:04:00 PM
619.2 USD
+0.48 (+0.08%)
After Hours: 1/16/2026, 8:04:00 PM
Fundamental Rating

5

Overall TMO gets a fundamental rating of 5 out of 10. We evaluated TMO against 57 industry peers in the Life Sciences Tools & Services industry. While TMO has a great profitability rating, there are some minor concerns on its financial health. TMO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year TMO was profitable.
  • TMO had a positive operating cash flow in the past year.
  • Each year in the past 5 years TMO has been profitable.
  • Each year in the past 5 years TMO had a positive operating cash flow.
TMO Yearly Net Income VS EBIT VS OCF VS FCFTMO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

  • The Return On Assets of TMO (6.38%) is better than 84.21% of its industry peers.
  • With an excellent Return On Equity value of 12.88%, TMO belongs to the best of the industry, outperforming 85.96% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 7.21%, TMO is doing good in the industry, outperforming 77.19% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for TMO is significantly below the industry average of 13.75%.
Industry RankSector Rank
ROA 6.38%
ROE 12.88%
ROIC 7.21%
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.8%
ROE(5y)15.76%
ROIC(3y)7.48%
ROIC(5y)8.55%
TMO Yearly ROA, ROE, ROICTMO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • The Profit Margin of TMO (15.02%) is better than 84.21% of its industry peers.
  • TMO's Profit Margin has been stable in the last couple of years.
  • TMO has a Operating Margin of 18.40%. This is amongst the best in the industry. TMO outperforms 82.46% of its industry peers.
  • In the last couple of years the Operating Margin of TMO has grown nicely.
  • TMO has a Gross Margin (41.43%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of TMO has remained more or less at the same level.
Industry RankSector Rank
OM 18.4%
PM (TTM) 15.02%
GM 41.43%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-6.24%
GM growth 5Y-1.42%
TMO Yearly Profit, Operating, Gross MarginsTMO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TMO is destroying value.
  • TMO has less shares outstanding than it did 1 year ago.
  • TMO has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for TMO has been reduced compared to a year ago.
TMO Yearly Shares OutstandingTMO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
TMO Yearly Total Debt VS Total AssetsTMO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

  • The Debt to FCF ratio of TMO is 5.84, which is a neutral value as it means it would take TMO, 5.84 years of fcf income to pay off all of its debts.
  • TMO's Debt to FCF ratio of 5.84 is fine compared to the rest of the industry. TMO outperforms 66.67% of its industry peers.
  • A Debt/Equity ratio of 0.62 indicates that TMO is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.62, TMO is doing worse than 68.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.84
Altman-Z N/A
ROIC/WACC0.67
WACC10.79%
TMO Yearly LT Debt VS Equity VS FCFTMO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • TMO has a Current Ratio of 1.50. This is a normal value and indicates that TMO is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.50, TMO is doing worse than 73.68% of the companies in the same industry.
  • A Quick Ratio of 1.11 indicates that TMO should not have too much problems paying its short term obligations.
  • The Quick ratio of TMO (1.11) is worse than 70.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.11
TMO Yearly Current Assets VS Current LiabilitesTMO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.53% over the past year.
  • TMO shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.12% yearly.
  • Looking at the last year, TMO shows a small growth in Revenue. The Revenue has grown by 3.22% in the last year.
  • TMO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.92% yearly.
EPS 1Y (TTM)4.53%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%9.66%
Revenue 1Y (TTM)3.22%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%4.94%

3.2 Future

  • TMO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.66% yearly.
  • TMO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.65% yearly.
EPS Next Y5.08%
EPS Next 2Y6.65%
EPS Next 3Y7.9%
EPS Next 5Y9.66%
Revenue Next Year3.54%
Revenue Next 2Y4.26%
Revenue Next 3Y4.7%
Revenue Next 5Y4.65%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TMO Yearly Revenue VS EstimatesTMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
TMO Yearly EPS VS EstimatesTMO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10 20 30

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 27.62 indicates a quite expensive valuation of TMO.
  • 77.19% of the companies in the same industry are more expensive than TMO, based on the Price/Earnings ratio.
  • TMO's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.47.
  • Based on the Price/Forward Earnings ratio of 24.88, the valuation of TMO can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of TMO indicates a somewhat cheap valuation: TMO is cheaper than 78.95% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of TMO to the average of the S&P500 Index (24.26), we can say TMO is valued inline with the index average.
Industry RankSector Rank
PE 27.62
Fwd PE 24.88
TMO Price Earnings VS Forward Price EarningsTMO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TMO is valued a bit cheaper than 68.42% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, TMO is valued a bit cheaper than 70.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF 38.05
EV/EBITDA 24.46
TMO Per share dataTMO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • TMO has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.43
PEG (5Y)2.28
EPS Next 2Y6.65%
EPS Next 3Y7.9%

6

5. Dividend

5.1 Amount

  • TMO has a yearly dividend return of 0.28%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.09, TMO pays a better dividend. On top of this TMO pays more dividend than 85.96% of the companies listed in the same industry.
  • With a Dividend Yield of 0.28, TMO pays less dividend than the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 0.28%

5.2 History

  • The dividend of TMO is nicely growing with an annual growth rate of 15.42%!
  • TMO has been paying a dividend for at least 10 years, so it has a reliable track record.
  • TMO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)15.42%
Div Incr Years7
Div Non Decr Years12
TMO Yearly Dividends per shareTMO Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • TMO pays out 9.48% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of TMO is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP9.48%
EPS Next 2Y6.65%
EPS Next 3Y7.9%
TMO Yearly Income VS Free CF VS DividendTMO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
TMO Dividend Payout.TMO Dividend Payout, showing the Payout Ratio.TMO Dividend Payout.PayoutRetained Earnings

THERMO FISHER SCIENTIFIC INC

NYSE:TMO (1/16/2026, 8:04:00 PM)

After market: 619.2 +0.48 (+0.08%)

618.72

-5.93 (-0.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-22
Earnings (Next)01-29
Inst Owners92.78%
Inst Owner Change-0.14%
Ins Owners0.1%
Ins Owner Change4.79%
Market Cap232.46B
Revenue(TTM)43.74B
Net Income(TTM)6.57B
Analysts83.13
Price Target661.6 (6.93%)
Short Float %1.36%
Short Ratio2.98
Dividend
Industry RankSector Rank
Dividend Yield 0.28%
Yearly Dividend1.52
Dividend Growth(5Y)15.42%
DP9.48%
Div Incr Years7
Div Non Decr Years12
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.99%
Min EPS beat(2)1.61%
Max EPS beat(2)4.37%
EPS beat(4)3
Avg EPS beat(4)1.9%
Min EPS beat(4)-0.07%
Max EPS beat(4)4.37%
EPS beat(8)5
Avg EPS beat(8)2.24%
EPS beat(12)7
Avg EPS beat(12)1.19%
EPS beat(16)11
Avg EPS beat(16)4.2%
Revenue beat(2)2
Avg Revenue beat(2)0.79%
Min Revenue beat(2)0.62%
Max Revenue beat(2)0.95%
Revenue beat(4)4
Avg Revenue beat(4)0.47%
Min Revenue beat(4)0.04%
Max Revenue beat(4)0.95%
Revenue beat(8)6
Avg Revenue beat(8)0.12%
Revenue beat(12)7
Avg Revenue beat(12)0.36%
Revenue beat(16)11
Avg Revenue beat(16)2.75%
PT rev (1m)2.37%
PT rev (3m)14.12%
EPS NQ rev (1m)0.04%
EPS NQ rev (3m)-1.03%
EPS NY rev (1m)0.01%
EPS NY rev (3m)1.02%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)1.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.76%
Valuation
Industry RankSector Rank
PE 27.62
Fwd PE 24.88
P/S 5.32
P/FCF 38.05
P/OCF 30.39
P/B 4.56
P/tB N/A
EV/EBITDA 24.46
EPS(TTM)22.4
EY3.62%
EPS(NY)24.86
Fwd EY4.02%
FCF(TTM)16.26
FCFY2.63%
OCF(TTM)20.36
OCFY3.29%
SpS116.41
BVpS135.81
TBVpS-38.61
PEG (NY)5.43
PEG (5Y)2.28
Graham Number261.62
Profitability
Industry RankSector Rank
ROA 6.38%
ROE 12.88%
ROCE 9.13%
ROIC 7.21%
ROICexc 7.52%
ROICexgc 33.37%
OM 18.4%
PM (TTM) 15.02%
GM 41.43%
FCFM 13.97%
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.8%
ROE(5y)15.76%
ROIC(3y)7.48%
ROIC(5y)8.55%
ROICexc(3y)8.22%
ROICexc(5y)9.55%
ROICexgc(3y)40.87%
ROICexgc(5y)46.64%
ROCE(3y)9.48%
ROCE(5y)10.9%
ROICexgc growth 3Y-8.22%
ROICexgc growth 5Y1.35%
ROICexc growth 3Y-8.88%
ROICexc growth 5Y2.89%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-6.24%
GM growth 5Y-1.42%
F-Score8
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.84
Debt/EBITDA 2.94
Cap/Depr 55.1%
Cap/Sales 3.52%
Interest Coverage 250
Cash Conversion 70.55%
Profit Quality 93%
Current Ratio 1.5
Quick Ratio 1.11
Altman-Z N/A
F-Score8
WACC10.79%
ROIC/WACC0.67
Cap/Depr(3y)51.6%
Cap/Depr(5y)63.11%
Cap/Sales(3y)3.9%
Cap/Sales(5y)4.54%
Profit Quality(3y)109.9%
Profit Quality(5y)104.9%
High Growth Momentum
Growth
EPS 1Y (TTM)4.53%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%9.66%
EPS Next Y5.08%
EPS Next 2Y6.65%
EPS Next 3Y7.9%
EPS Next 5Y9.66%
Revenue 1Y (TTM)3.22%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%4.94%
Revenue Next Year3.54%
Revenue Next 2Y4.26%
Revenue Next 3Y4.7%
Revenue Next 5Y4.65%
EBIT growth 1Y8.68%
EBIT growth 3Y-9.38%
EBIT growth 5Y12.7%
EBIT Next Year15.31%
EBIT Next 3Y9.32%
EBIT Next 5Y9.16%
FCF growth 1Y-6.66%
FCF growth 3Y2.29%
FCF growth 5Y12.42%
OCF growth 1Y-6.36%
OCF growth 3Y-2.36%
OCF growth 5Y11.75%

THERMO FISHER SCIENTIFIC INC / TMO FAQ

What is the ChartMill fundamental rating of THERMO FISHER SCIENTIFIC INC (TMO) stock?

ChartMill assigns a fundamental rating of 5 / 10 to TMO.


What is the valuation status of THERMO FISHER SCIENTIFIC INC (TMO) stock?

ChartMill assigns a valuation rating of 4 / 10 to THERMO FISHER SCIENTIFIC INC (TMO). This can be considered as Fairly Valued.


What is the profitability of TMO stock?

THERMO FISHER SCIENTIFIC INC (TMO) has a profitability rating of 7 / 10.


What is the financial health of THERMO FISHER SCIENTIFIC INC (TMO) stock?

The financial health rating of THERMO FISHER SCIENTIFIC INC (TMO) is 4 / 10.


What is the expected EPS growth for THERMO FISHER SCIENTIFIC INC (TMO) stock?

The Earnings per Share (EPS) of THERMO FISHER SCIENTIFIC INC (TMO) is expected to grow by 5.08% in the next year.